Growth Advisory and Digital Transformation
Accelerating digital health technology adoption, growth and operational efficiency
enterprise insurers, health and life science companies
Staying ahead of the curve to meet shareholders mandates is not easy. This is more pronounced in 2020 with the COVID-19 pandemic and the . The rapid adoption of digital health technology such as telemedicine consults and remote monitoring has never looked so promising. We are on a mission to support payers, health and life science companies adapt to the impending changes that will impact the delivery, financing and servicing of healthcare for millions of people forever.
Our Managing Consultant, Chaney Ojinnaka has navigated such challenges for Fortune 500 insurers and high growth health and life science firms. A business development, product innovation and digital transformation expert, he has led the development and optimization of new and existing products and solutions for some of the most innovative health companies in the US and globally.
His particular area of expertise addresses how organizations can be agile and adapt to changes in consumer demographics (ie aging, sicker population); plan for changes to government/payer reimbursement mandates; facilitate technology partnerships; and deal with increasing privacy requirements in handling consumer data for artificial intelligence (AI) and process innovations. He has over a decade of experience at firms such as Aetna (a CVS company), Humana including advising foreign governments, high growth health and life science companies and family offices on health care digital strategy. Chaney has an MBA from the University of Chicago, is an Adjunct Faculty at NYU, and mentors for a number of accelerators such as Techstars.
Partnerships and Business Development
In today’s hyper competitive market, integrated partnerships is a great way to get ahead in digital health. With so many digital health new entrants in the last five years, filtering through the landscape is one challenge while getting the most promising partners to the negotiating table is another feat. Most challenging is figuring out what a deal looks like to incentive your partner and capture the most value, for example is it revenue share, licensing or a joint venture.
With compliance regulation and vertical integration taking place among the largest insurers, medical device and life science firms, exploring effective products and business models is one sure way to survive. Guided by the market, data and industry experience on what works, we’ll work with your product team and review the current product portfolio, identifying quick win product feature enhancements and a roadmap that will meet consumer, provider and regulatory requirements.
Evaluating success of existing solutions to determine digital transformation needs can be challenging considering big data volumes and noise especially in areas such as health records, billing, claims, customer service, messaging, and personalization. We can support your team in how to use internal data, external data, and development resources in process innovation, and machine learning.